Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M305963200 on June 25, 2003

J. Biol. Chem., Vol. 278, Issue 36, 33763-33773, September 5, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/36/33763    most recent
M305963200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Recchi, C.
Right arrow Articles by Reyrat, J.-M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Recchi, C.
Right arrow Articles by Reyrat, J.-M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Mycobacterium tuberculosis Rv1395 Is a Class III Transcriptional Regulator of the AraC Family Involved in Cytochrome P450 Regulation*

Chiara Recchi {ddagger} §, Bianca Sclavi ¶, Jean Rauzier {ddagger}, Brigitte Gicquel {ddagger} and Jean-Marc Reyrat {ddagger} ||

From the {ddagger}Unité de Génétique Mycobactérienne, Institut Pasteur, 25, Rue du Dr. Roux, 75724 Paris cedex 15 and the Unité d'Enzymologie et Cinétique Structurale, CNRS/Ecole Normale Supérieure de Cachan, 61, Avenue du President Wilson, 94230 Cachan, France

Rv1395 is annotated as a potential transcriptional regulator of the AraC family. The Rv1395 insertional mutant was identified in a signature tag mutagenesis study in Mycobacterium tuberculosis and was shown to be attenuated in the lungs of mice. Here, we used comparative genomics and biochemical methods to show that Rv1395 is unique to the M. tuberculosis complex and that it encodes a protein that binds the region between two divergent genes, a member of the cytochrome P450 family (Rv1394c or cyp132) and Rv1395 itself. Rv1395 binds to this DNA region by its helix-turn-helix-containing C-terminal domain, and it recognizes two sites with different affinity. We identified the transcriptional start points (TSP) of Rv1394c and Rv1395: both genes have two TSPs, three of which are located in the intergenic region. We constructed and compared various transcriptional fusions consisting of the promoter regions and a reporter gene in Mycobacterium smegmatis: this showed that Rv1395 induces the expression of the cytochrome P450 gene (Rv1394c) and represses its own transcription. This was confirmed in M. tuberculosis when the wild type and a Rv1395-overexpressing strain were used as hosts for the fusions. Site-directed mutagenesis showed that Rv1395 binds to the two sites in a co-operative manner and that binding to both sites is required for Rv1395 optimal activity. A model describing the potential mode of action of Rv1395 is discussed.


Received for publication, June 6, 2003 , and in revised form, June 20, 2003.

* This work was supported in part by NIAID, National Institutes of Health (support for sequencing the M. smegmatis and M. avium genomes) and by the European TB Vaccine Cluster. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Supported by the Fondation pour la Recherche Médicale.

|| To whom correspondence should be addressed (present address): Unité Inserm U570, Faculté deMédecine Necker-Enfants Malades, 156 Rue de Vaugirard, 75730 Paris cedex 15, France. Tel.: 33-1-40-61-53-71; Fax: 33-1-40-61-56-77; E-mail: jmreyrat{at}necker.fr.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
H. Ouellet, L. M. Podust, and P. R. O. de Montellano
Mycobacterium tuberculosis CYP130: CRYSTAL STRUCTURE, BIOPHYSICAL CHARACTERIZATION, AND INTERACTIONS WITH ANTIFUNGAL AZOLE DRUGS
J. Biol. Chem., February 22, 2008; 283(8): 5069 - 5080.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
C. C. Frota, K. G. Papavinasasundaram, E. O. Davis, and M. J. Colston
The AraC Family Transcriptional Regulator Rv1931c Plays a Role in the Virulence of Mycobacterium tuberculosis
Infect. Immun., September 1, 2004; 72(9): 5483 - 5486.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Sandu, C. B. Chiribau, and R. Brandsch
Characterization of HdnoR, the Transcriptional Repressor of the 6-Hydroxy-D-nicotine Oxidase Gene of Arthrobacter nicotinovorans pAO1, and its DNA-binding Activity in Response to L- and D-Nicotine Derivatives
J. Biol. Chem., December 19, 2003; 278(51): 51307 - 51315.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement